Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | ZVRA | ACHV | ||
| Company | Pyxis Oncology Inc | Zevra Therapeutics Inc | Achieve Life Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.18 | 4.52 | 4.71 | ||
| High | 3.18 | 4.66 | 4.76 | ||
| Low | 2.92 | 4.32 | 4.58 | ||
| Last | 2.94 | 4.36 | 4.59 | ||
| Change | -0.26 | -0.15 | -0.19 | ||
| % Change | -8.13% | -3.33% | -3.97% | ||
| Volume | 893,200 | 230,700 | 153,800 | ||
| 20-Day Average Volume | 852,510 | 258,610 | 458,705 | ||
| Previous Close | 3.20 | 4.51 | 4.78 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.50 | 4.65 | 4.98 | ||
| 20-Day Raw Stochastic | 1.69% | 7.87% | 5.71% | ||
| 20-Day Relative Strength | 32.89% | 42.16% | 42.80% | ||
| Weighted Alpha | -36.83 | -24.90 | +18.54 | ||
| Today's Opinion | 40% Sell | 88% Sell | 24% Buy | ||
| Previous Opinion | 40% Sell | 80% Sell | 56% Buy | ||
| Last Month's Opinion | 8% Buy | 88% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.92% since 06/25/24 | -5.01% since 06/25/24 | -1.08% since 06/25/24 | ||
| Low | 2.92 on 07/02/24 | 4.32 on 07/02/24 | 4.53 on 06/28/24 | ||
| High | 3.50 on 06/28/24 | 5.05 on 07/01/24 | 5.01 on 06/27/24 | ||
| 1-Month | |||||
| %Chg | -21.39% since 05/31/24 | -6.24% since 05/31/24 | -12.07% since 05/31/24 | ||
| Low | 2.92 on 07/02/24 | 4.29 on 06/21/24 | 4.53 on 06/28/24 | ||
| High | 4.10 on 06/12/24 | 5.20 on 06/03/24 | 5.58 on 06/04/24 | ||
| 3-Month | |||||
| %Chg | -45.35% since 04/02/24 | -14.76% since 04/02/24 | +2.46% since 04/02/24 | ||
| Low | 2.92 on 07/02/24 | 4.29 on 06/21/24 | 4.20 on 04/15/24 | ||
| High | 6.18 on 04/03/24 | 5.30 on 05/07/24 | 5.59 on 05/29/24 | ||
| 6-Month | |||||
| %Chg | +42.72% since 01/02/24 | -36.16% since 01/02/24 | +10.07% since 01/02/24 | ||
| Low | 1.95 on 01/03/24 | 4.29 on 06/21/24 | 3.75 on 01/05/24 | ||
| High | 6.85 on 02/27/24 | 7.28 on 02/20/24 | 5.59 on 05/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 173,131 | 182,479 | 157,625 | ||
| Shares Outstanding, K | 58,888 | 41,853 | 34,341 | ||
| Annual Sales | 0 | 27,460,000 | 0 | ||
| Annual Net Income | -73,790,000 | -46,050,000 | -29,820,000 | ||
| Last Quarter Sales | 16,150,000 | 3,430,000 | 0 | ||
| Last Quarter Net Income | -3,260,000 | -16,620,000 | -6,490,000 | ||
| 60-Month Beta | 1.28 | 1.97 | 1.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 05/14/24 | -0.40 on 05/08/24 | -0.26 on 05/09/24 | ||
| Latest Earnings Date | 08/09/24 | 08/12/24 | 08/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||